Human RPL15/EC45/RPL10 ORF/cDNA clone-Adenovirus plasmid (BC071672)
Cat. No.: pGMAP000374
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human RPL15/EC45/RPL10 adenoviral expression plasmid for RPL15 adenovirus packaging, RPL15 adenovirus.
Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.
Go to
RPL15/EC45 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMAP000374 |
| Gene Name | RPL15 |
| Accession Number | BC071672 |
| Gene ID | 6138 |
| Species | Human |
| Product Type | Adenovirus plasmid (overexpression) |
| Insert Length | 615 bp |
| Gene Alias | EC45,RPL10,RPLY10,RPYL10 |
| Fluorescent Reporter | GFP |
| Mammalian Cell Selection | Null |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | EF1 |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGGTGCATACAAGTACATCCAGGAGCTATGGAGAAAGAAGCAGTCTGATGTCATGCGCTTTCTTCTGAGGGTCCGCTGCTGGCAGTACCGCCAGCTCTCTGCTCTCCACAGGGCTCCCCGCCCCACCCGGCCTGATAAAGCGCGCCGACTGGGCTACAAGGCCAAGCAAGGTTACGTTATATATAGGATTCGTGTTCGCCGTGGTGGCCGAAAACGCCCAGTTCCTAAGGGTGCAACTTACGGCAAGCCTGTCCATCATGGTGTTAACCAGCTAAAGTTTGCTCGAAGCCTTCAGTCCGTTGCAGAGGAGCGAGCTGGACGCCACTGTGGGGCTCTGAGAGTCCTGAATTCTTACTGGGTTGGTGAAGATTCCACATACAAATTTTTTGAGGTTATCCTCATTGATCCATTCCATAAAGCTATCAGAAGAAATCCTGACACCCAGTGGATCACCAAACCAGTCCACAAGCACAGGGAGATGCGTGGGCTGACATCTGCAGGCCGAAAGAGCCGTGGCCTTGGAAAGGGCCACAAGTTCCACCACACTATTGGTGGCTCTCGCCGGGCAGCTTGGAGAAGGCGCAATACTCTCCAGCTCCACCGTTACCGCTAA |
| ORF Protein Sequence | MGAYKYIQELWRKKQSDVMRFLLRVRCWQYRQLSALHRAPRPTRPDKARRLGYKAKQGYVIYRIRVRRGGRKRPVPKGATYGKPVHHGVNQLKFARSLQSVAEERAGRHCGALRVLNSYWVGEDSTYKFFEVILIDPFHKAIRRNPDTQWITKPVHKHREMRGLTSAGRKSRGLGKGHKFHHTIGGSRRAAWRRRNTLQLHRYR |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T73230-Ab | Anti-RPL15 monoclonal antibody |
| Target Antigen | GM-Tg-g-T73230-Ag | RPL15 protein |
| ORF Viral Vector | pGMLP003155 | Human RPL15 Lentivirus plasmid |
| ORF Viral Vector | pGMLV000358 | Human RPL15 Lentivirus plasmid |
| ORF Viral Vector | pGMAP000374 | Human RPL15 Adenovirus plasmid |
| ORF Viral Vector | pGMPC000783 | Human RPL15 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLP003155 | Human RPL15 Lentivirus particle |
| ORF Viral Vector | vGMLV000358 | Human RPL15 Lentivirus particle |
| ORF Viral Vector | vGMAP000374 | Human RPL15 Adenovirus particle |
Target information
| Target ID | GM-T73230 |
| Target Name | RPL15 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
6138 |
| Gene ID |
100051688 (Equus caballus), 101083198 (Felis catus), 245981 (Rattus norvegicus), 477046 (Canis lupus familiaris) 507151 (Bos taurus), 6138 (Homo sapiens), 66480 (Mus musculus), 701255 (Macaca mulatta) |
| Gene Symbols & Synonyms | RPL15,Rpl15,Rpl10,L15,EC45,eL15,DBA12,RPL10,RPLY10,RPYL10,2510008H07Rik |
| Target Alternative Names | 2510008H07Rik,60S ribosomal protein L15,DBA12,EC45,L15,Large ribosomal subunit protein eL15,RPL10,RPL15,RPLY10,RPYL10,Rpl10,Rpl15,eL15 |
| Uniprot Accession |
E2QXF3,P61313,P61314,Q5EAD6,Q9CZM2
Additional SwissProt Accessions: P61314,E2QXF3,Q5EAD6,P61313,Q9CZM2 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | Therapeutics Target |
| Disease | |
| Disease from KEGG | |
| Gene Ensembl | ENSECAG00000010157, ENSCAFG00845019729, ENSBTAG00000033080, ENSG00000174748, ENSMUSG00000012405, ENSMMUG00000006353 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


